The cost of end-of-life hospitalizations for lung disease varies widely, averaging $29,981 per patient; this raises the question of whether lung transplantation could avert acute care costs for some patients. @CarliLehrMDPhD @DaltonJarrod@MValapour
https://t.co/KKUv4H7E8J
Is there a better way to capture waitlist mortality risk for #LungTx patients? Using clinically-interpretable dimensions leads to improved phenotyping and better understanding of mortality risk. @CarliLehrMDPhD @MValapour@DaltonJarrod
🔗https://t.co/5KCDX3qaRC
Higher utilization of ECMO bridge to transplant and increased waitlist mortality found using newly collected OPTN/UNOS data. Continued efforts are needed to ensure timely access to transplant for this population. @CarliLehrMD @MValapour
🔗: https://t.co/3LqZ5UvUY6
Cleveland Clinic researchers develop a new model for prioritizing patients waiting for a lung transplant.
The goal is to improve outcomes and reduce deaths among those in need of donor lungs.
https://t.co/HyRK899bKG
If you haven't already transported yourself away from X, here's my latest paper on transportability:
https://t.co/16ZS5QU2EX
Featuring: adaptive treatment strategies, kidney-pancreas transplant, @docvock, @SRTRNews, and more!
" ... racial differences in post-transplant outcomes still exist and must be studied further to achieve improved #equity in the U.S. #transplant system," @CarliLehrMDPhD, at @ClevelandClinic, told Healio. https://t.co/JpeU4IQFI0
New 🇺🇸 data demonstrates higher than previously reported waitlist mortality for 🫁#transplant candidates supported with ECMO. Important work by @CarliLehrMDPhD & @MValapour ⬇️⬇️⬇️⬇️ https://t.co/mMuHdBTDny
To keep up to date with all the happenings at @nih_nhlbi Follow us there for the latest heart, lung, blood and sleep news, research results, funding opportunities, and more. Learn more: https://t.co/8FqPxCu53M.
Great Invited Expert Opinion in #JTCVS comparing longevity of patients with cystic fibrosis in the US vs Canada. By Dr Joel Cooper et al: https://t.co/84LoyUk8Eg
@AATSHQ@tssmn@MValapour@MarceloCypel
Plus a Commentary by Harris, @mghartwigmd et al: https://t.co/XrvffosB6Z
Socioeconomic position and region differences did not explain most of the differences in post-lung transplant survival by race and ethnicity, highlighting the complex social reality in racial disparities in post-transplant outcomes. https://t.co/ycBYVuKFdV
Important work by @CarliLehrMDPhD that, as the accompanying editorial by Drs. Ayodeji Adegunsoye and Milda Saunders at @UChicagoMed discuss so eloquently, asks more questions than it answers.
https://t.co/DCfvtl1ol8
A study from @ClevelandClinic and @SRTRNews finds a new method of donor-lung distribution is expected to decrease deaths among those waiting for a lung transplant.
https://t.co/XMWDTvTD6v